一种对不对称的二甲基氨酸合成受体
Lindsey I James1, Joshua E Beaver, Natalie W Rice
1Department of Chemistry, CB 3290, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Journal of the American Chemical Society
|April 9, 2013
概括
研究人员开发了一种新的小分子受体,A2D,用于检测不对称二甲基氨酸 (aRMe2),这是一种与各种疾病相关的蛋白质修饰. 这一发现为针对这些疾病的新诊断和治疗策略提供了潜力.
科学领域:
- 化学生物学 化学生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 非对称二甲基氨酸 (aRMe2) 是一种关键的翻译后蛋白质修饰 (PTM),与癌症和神经退行性疾病等各种疾病有关.
- 了解aRMe2识别的分子机制对于开发向疗法至关重要.
研究的目的:
- 确定和描述一种新的小分子受体,能够选择性地与不对称的二甲基氨酸 (aRMe2) 结合.
- 为了研究与aRMe2.的鉴定受体的结合亲和力,选择性和相互作用模式.
主要方法:
- 动态组合化学被用来发现小分子受体A2D.
- 对二甲基氨酸的异构形式进行了结合亲和性和选择性的评估.
- 进行了受体-PTM复合体的结构性表征,以阐明结合相互作用.
主要成果:
- 一种新的小分子受体,A2D,被确定为不对称的二甲基氨酸 (aRMe2).
- A2D显示对aRMe2具有2.5-7.5倍的选择性,超过对称的二甲基氨酸,具有较低的微分子结合亲和度.
- 分离子-π相互作用被确定为A2D-aRMe2结合的主要驱动力,模仿自然蛋白质识别.
结论:
- 新型小分子受体A2D为aRMe2.提供了对aRMe2.的选择性化学探针.
- 这些发现为设计调节aRMe2-蛋白相互作用的小分子提供了基础,以获得治疗益处.
- 这项工作促进了对合成受体对PTM识别的理解.
相关概念视频
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Internal Receptors
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

